A drug under investigation by Sanofi for multiple sclerosis improved several measures of disease activity in patients, according to results of a late-stage clinical trial.
The Food and Drug Administration has approved a new use for a drug made by Novartis for treating multiple sclerosis, the Swiss drug maker's U.S. subsidiary said Monday.
A University of Maryland pharmacy professor won top honors last week for his work developing a means of measuring oxygen levels in the brain, the university said Monday.